Locus Biosciences competitorsClear all

Locus Biosciences's top competitors include Spring Bank Pharmaceuticals, TCR2 Therapeutics, MetaboGen AB and GenVec.
Locus Biosciences
Locus Biosciences
Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome.
Spring Bank Pharmaceuticals
Spring Bank Pharmaceuticals
Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
TCR2 Therapeutics
TCR2 Therapeutics
TCR , Inc. is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy.
MetaboGen AB
MetaboGen AB
As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease.
GenVec
GenVec
GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.
Founding Date
Founding Date
2015
Founding Date
2002
Founding Date
2015
Founding Date
2011
Founding Date
1992
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Raleigh, US HQ
Locations
Hopkinton, US HQ
Milford, US
Locations
Cambridge, US HQ
Locations
Landala, SE HQ
Locations
Gaithersburg, US HQ
Employees
Employees
422% decrease
Employees
2938% increase
Employees
445% increase
Employees
433% increase
Employees
N/A
Valuation ($)
Valuation ($)
N/A
Valuation ($)
80.6 m
Valuation ($)
392.6 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
757
Twitter followers
1.2 k
Twitter followers
N/A
Twitter followers
48
Twitter followers
268
Alexa Website Rank
Alexa Website Rank
339866
Alexa Website Rank
471158
Alexa Website Rank
647278
Alexa Website Rank
631819
Alexa Website Rank
1298313

Financial

Net income
Net income
N/A
Net income
($22.9m) (FY, 2018)
Net income
($13.1m) (FY, 2017)
Net income
N/A
Net income
($5.8m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 19m
Total funding raised
$ 14.4m
Total funding raised
$ 173.3m
Total funding raised
N/A
Total funding raised
$ 2m
For sources of this data, please see the company profile

View company profiles

Spring Bank Pharmaceuticals
HQ
Hopkinton, US
Employees
29↑ 38% increase

Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.

View company
TCR2 Therapeutics
HQ
Cambridge, US
Employees
44↑ 5% increase

TCR , Inc. is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy.

View company
MetaboGen AB
HQ
Landala, SE
Employees
4↑ 33% increase

As a pioneering company, MetaboGen is addressing the microbiome to understand health and disease.

View company
GenVec
HQ
Gaithersburg, US

GenVec is a clinical-stage biopharmaceutical company focusing on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform.

View company